Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 2
1996 4
1997 4
1998 7
1999 3
2000 7
2001 4
2002 6
2003 14
2004 10
2005 8
2006 9
2007 19
2008 14
2009 19
2010 21
2011 23
2012 18
2013 24
2014 33
2015 39
2016 41
2017 43
2018 34
2019 23
2020 30
2021 37
2022 24
Text availability
Article attribute
Article type
Publication date

Search Results

465 results
Results by year
Filters applied: . Clear all
Page 1
SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants.
Tea F, Ospina Stella A, Aggarwal A, Ross Darley D, Pilli D, Vitale D, Merheb V, Lee FXZ, Cunningham P, Walker GJ, Fichter C, Brown DA, Rawlinson WD, Isaacs SR, Mathivanan V, Hoffmann M, Pöhlman S, Mazigi O, Christ D, Dwyer DE, Rockett RJ, Sintchenko V, Hoad VC, Irving DO, Dore GJ, Gosbell IB, Kelleher AD, Matthews GV, Brilot F, Turville SG. Tea F, et al. Among authors: dore gj. PLoS Med. 2021 Jul 6;18(7):e1003656. doi: 10.1371/journal.pmed.1003656. eCollection 2021 Jul. PLoS Med. 2021. PMID: 34228725 Free PMC article.
Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial.
Grebely J, Dalgard O, Conway B, Cunningham EB, Bruggmann P, Hajarizadeh B, Amin J, Bruneau J, Hellard M, Litwin AH, Marks P, Quiene S, Siriragavan S, Applegate TL, Swan T, Byrne J, Lacalamita M, Dunlop A, Matthews GV, Powis J, Shaw D, Thurnheer MC, Weltman M, Kronborg I, Cooper C, Feld JJ, Fraser C, Dillon JF, Read P, Gane E, Dore GJ; SIMPLIFY Study Group. Grebely J, et al. Among authors: dore gj. Lancet Gastroenterol Hepatol. 2018 Mar;3(3):153-161. doi: 10.1016/S2468-1253(17)30404-1. Epub 2018 Jan 6. Lancet Gastroenterol Hepatol. 2018. PMID: 29310928 Free article. Clinical Trial.
Empfehlungen zur Hepatitis Versorgung bei Drogenkonsumierenden.
Grebely J, Robaeys G, Bruggmann P, Aghemo A, Backmund M, Bruneau J, Byrne J, Dalgard O, Feld JJ, Hellard M, Hickman M, Kautz A, Litwin A, Lloyd AR, Mauss S, Prins M, Swan T, Schaefer M, Taylor LE, Dore GJ; im Namen vom International Network on Hepatitis care in Substance Users. Grebely J, et al. Among authors: dore gj. Int J Drug Policy. 2015 Nov 28:S0955-3959(15)00352-7. doi: 10.1016/j.drugpo.2015.11.010. Online ahead of print. Int J Drug Policy. 2015. PMID: 26749563 German. No abstract available.
Hepatitis C elimination in Australia: progress and challenges.
Martinello M, Hajarizadeh B, Dore GJ. Martinello M, et al. Among authors: dore gj. Med J Aust. 2020 May;212(8):362-363. doi: 10.5694/mja2.50584. Epub 2020 Apr 19. Med J Aust. 2020. PMID: 32306399 No abstract available.
Observations on the launch of new drugs for hepatitis C.
Martinello M, Hajarizadeh B, Dore GJ. Martinello M, et al. Among authors: dore gj. Aust Prescr. 2018 Feb;41(1):4-5. doi: 10.18773/austprescr.2018.005. Epub 2018 Feb 1. Aust Prescr. 2018. PMID: 29507451 Free PMC article. No abstract available.
465 results